Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$17.3B
sum of reported positions
Reported positions
354
Changes vs prior quarter
395
84 new · 85 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 396 measured positions in 8 quarters, the typical new or larger position finished −3.9 pts against the S&P 500 and 42% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 985K | $470M | 2.7% | |
| 6.85M | $322M | 1.9% | |
| 959K | $321M | 1.9% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $13.6B | $17.3B |
| Positions | 355 | 354 |
| Biggest line | — | Taiwan Semiconductor Manufacturing 3% |
| 4.42M |
| $267M |
| 1.5% |
| 786K | $262M | 1.5% |
| 2.8M | $249M | 1.4% |
Crinetics Pharmaceuticals Inc | 6.46M | $242M | 1.4% |
Apogee Therapeutics Inc | 1.74M | $231M | 1.3% |
| 1.53M | $230M | 1.3% |
| 6.72M | $223M | 1.3% |
| 557K | $217M | 1.3% |
| 4.73M | $192M | 1.1% |
| 497K | $189M | 1.1% |
| 1.31M | $187M | 1.1% |
| 229K | $174M | 1.0% |
| 1.77M | $171M | 1.0% |
| 6.16M | $152M | 0.9% |
| 4.43M | $148M | 0.9% |
| 1.21M | $144M | 0.8% |
| 1.56M | $142M | 0.8% |
| 517K | $141M | 0.8% |
| 227K | $140M | 0.8% |
| 4.83M | $140M | 0.8% |
| 1.99M | $138M | 0.8% |
| 355K | $134M | 0.8% |
MYR Group, Inc. (MYRG)
238K → 109K shares (−54%)
InterDigital (IDCC)
418K → 190K shares (−55%)
SPX Technologies (SPXC)
280K → 205K shares (−27%)
Teradyne (TER)
185K → 103K shares (−44%)
Ormat Technologies (ORA)
472K → 425K shares (−10%)
Grupo Financiero Galicia (GGAL)
1.07M → 860K shares (−19%)
LivaNova (LIVN)
544K → 516K shares (−5%)
Madrigal Pharmaceuticals (MDGL)
111K → 78K shares (−30%)
Matador Resources (MTDR)
1.19M → 829K shares (−30%)
ATI Inc. (ATI)
213K → 205K shares (−4%)
Tidewater, Inc. (TDW)
759K → 558K shares (−26%)
Federal Signal Corporation (FSS)
339K → 286K shares (−16%)
Graham (GHM)
343K → 293K shares (−15%)
Victoria's Secret (VSXY)
797K → 434K shares (−46%)
RBC Bearings (RBC)
68K → 56K shares (−17%)
Lincoln Electric (LECO)
144K → 135K shares (−6%)
Legence (LGN)
915K → 408K shares (−55%)
Happen (HAPN)
2.01M → 1.6M shares (−20%)
Babcock & Wilcox Enterprises (BW)
2.38M → 2.34M shares (−2%)
Sociedad Quimica y Minera de C
867K → 438K shares (−50%)
Uranium Energy (UEC)
8.33M → 2.92M shares (−65%)
Quanta Services (PWR)
101K → 42K shares (−58%)
ArcBest Corp. (ARCB)
210K → 203K shares (−4%)
Allient (ALNT)
374K → 282K shares (−25%)
Dianthus Therapeutics, Inc. (DNTH)
317K → 295K shares (−7%)
